Patents by Inventor Todd Zahn

Todd Zahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220144737
    Abstract: Disclosed herein are embodiments of a method for making cannabidiol. Also disclosed herein are embodiments of a composition comprising cannabidiol and one or more GRAS components. The method and composition embodiments described herein address the drawbacks associated with conventional methods for making and/or isolating cannabidiol.
    Type: Application
    Filed: January 26, 2022
    Publication date: May 12, 2022
    Applicant: PureForm Global, Inc.
    Inventors: Marc Bencivenga, Matthew Forster, Paul Herrinton, Paul Jass, Surendra Singh, Todd Zahn
  • Patent number: 11267774
    Abstract: Disclosed herein are embodiments of a method for making cannabidiol. Also disclosed herein are embodiments of a composition comprising cannabidiol and one or more GRAS components. The method and composition embodiments described herein address the drawbacks associated with conventional methods for making and/or isolating cannabidiol.
    Type: Grant
    Filed: February 28, 2020
    Date of Patent: March 8, 2022
    Assignee: PureForm Global, Inc.
    Inventors: Marc Bencivenga, Matthew Forster, Paul Herrinton, Paul Jass, Surendra Singh, Todd Zahn
  • Publication number: 20200199056
    Abstract: Disclosed herein are embodiments of a method for making cannabidiol. Also disclosed herein are embodiments of a composition comprising cannabidiol and one or more GRAS components. The method and composition embodiments described herein address the drawbacks associated with conventional methods for making and/or isolating cannabidiol.
    Type: Application
    Filed: February 28, 2020
    Publication date: June 25, 2020
    Applicant: PureForm Global, Inc.
    Inventors: Marc Bencivenga, Matthew Forster, Paul Herrinton, Paul Jass, Surendra Singh, Todd Zahn
  • Publication number: 20180134730
    Abstract: The present disclosure relates to an improved process for the preparation of 3-boryl substituted azaindole compounds in high yields and high selectivity. Such azaindole compounds may be used as intermediates to form compounds with cytotoxic, anticancer, and antiviral activities.
    Type: Application
    Filed: May 9, 2016
    Publication date: May 17, 2018
    Inventors: Sarah Caruso, Matthew Forster, Andrew Cipa, Mark Marlatt, Todd Zahn, Paul Herrinton